In Poland, as in other European countries, there is a continuous increase in the demand for health services in the field of hematooncology. This phenomenon is due not only to the increased incidence of cancers of the hematopoietic and lymphatic systems, which has been observed for several decades, but also to the dynamic recent development of diagnostic and treatment methods. These advances, on the one hand, make it possible to prolong the survival of patients and often a cure, but on the other hand, they generate ever-increasing treatment costs. In recent years, Poland has seen a breakthrough in securing patient access to modern treatment. Reimbursement decisions by the Minister of Health have provided clinicians with therapeutic tools to increase the effectiveness and safety of therapy in hematooncology, including chronic lymphocytic leukemia. No less dynamic advances in medicine bring new therapeutic possibilities, which implies the need to update therapeutic standards and, consequently, to further expand patient access to new therapies and optimize care models in accordance with the concept of Value Based Healthcare. The latest European guidelines (ESMO) indicate the new possibilities and opportunities that PBL patients are obtaining. The discussion will be canvassed by a study prepared by experts, which aims to provide an overview of the latest guidelines for diagnosis and treatment, as well as directions for changes in the model of care in anticipation of further growth in healthcare value in this area. Invited to participate in the conference were Maciej Miłkowski, Undersecretary of State at the Ministry of Health, prof. dr hab. n. med. Ewa Lech-Marańda, Director of the Institute of Hematology and Transfusiology in Warsaw, National Consultant in Hematology, prof. dr hab. n. med. Iwona Hus, Head of the Hematology Clinic of the National Medical Institute of the Ministry of Internal Affairs and Administration in Warsaw, prof. dr hab. n. med. Krzysztof Giannopoulos, President of the Polish Society of Hematologists and Transfusiologists, prof. dr hab. n. med. Krzysztof Jamroziak, Acting Deputy Head of the Department of Hematology, Transplantation and Internal Diseases at the Warsaw Medical University, dr hab. Joanna Didkowska, Head of the Department of Epidemiology and Primary Prevention of Cancer and the National Cancer Registry, M. Sklodowska-Curie National Cancer Institute - National Research Institute in Warsaw. The conference entitled. "Chronic lymphocytic leukemia - a new opening. Opportunities to increase health value," will be held on January 25, 2024, at 10:00 am, in a hybrid format at the headquarters of the Polish Press Agency, Warsaw, 6/8 Bracka Street.. Online participation possible after prior registration via link: 

https://us06web.zoom.us/webinar/register/WN_23DR15glRLOEtntj_3l9CA. Live streaming at: https://cofvbhc.pl/